Dark

SMMT
Summit Therapeutics Inc. Common Stock
stock NASDAQ

At Close

Sep 22, 2026 3:59:59 PM EDT

17.11USD+1.243%(+0.21)4,555,037

16.10Bid 17.96Ask 1.86Spread

Pre-market

Sep 22, 2026 9:28:30 AM EDT

17.00USD+0.592%(+0.10)8,587

After-hours

Sep 22, 2026 4:27:30 PM EDT

16.91USD-1.169%(-0.20)682

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

13.65B

Headquarters

OXFORDSHIRE, GBR

Industry

Biotechnology

Next Earnings

Oct 19, 2026 (27d)

SRPT ACER XLV

SMMT Stats

Avg. Vol. 10 Day

6,458,673

Avg. Vol. 30 Day

6,448,784

Employees

Market Cap

13,653,484,438

Shares Out.

797,749,602

On/Off Exchange

58%/42%

6 Month Beta

1.59

1 Year Beta

1.68

2 Year Beta

1.63

3 Year Beta

1.41

52 Week Low

12.07

52 Week High

29.23

SMA50

14.70

SMA200

16.43

1 Week

-1.64%

1 Month

+30.05%

3 Month

+19.85%

6 Month

+9.71%

1 Year

-10.39%

2 Year

-21.89%

5 Year

+230.41%

Profile

summit is a uk company focused on the discovery and development of novel drug candidates to treat areas of high unmet medical need. our strategy focuses on two therapy areas: duchenne muscular dystrophy, a fatal genetic muscle wasting disease and the infectious disease caused by the bacteria c. difficile.

SMMT Stock Summary

Summit Therapeutics Inc. Common Stock (NASDAQ:SMMT) stock price today is $17.11, and today's volume is 4,555,037. SMMT is up 1.243% today. The 30 day average volume is 6,448,784. SMMT market cap is 13.65B with 797,749,602 shares outstanding.